Takehiko Kaneko, Chief Medical Officer of Heartseed Inc., was intervieed by RegMedNet and talked about cardiac regenerative medicine.

Kaneko explained Heartseed's mission and gave an insight into the current trends in the field of cardiac regenerative medicine. Additionally, Kaneko discussed some of the most important factors when it comes to for efficient cardiomyocyte differentiation and shared how spheroids are used during transplantation of cardiomyocytes.

Please take a look at the article from the link.

[About RegMedNet]

RegMedNet is a community site that unites the diverse regenerative medicine and advanced therapies community. Through partnership with thier sister journal, Regenerative Medicine, they seek to educate and inspire to help this exciting field move forward at an even faster rate.  

On RegMedNet, you can find free educational webinars, expert opinion and insight, and exclusive peer-reviewed journal articles, as well as the latest news and advances. You can watch, listen and read about every step in the regenerative medicine and cell and gene therapy pipeline, from development, clinical trial and manufacture to regulation and commercialization, all in one place.